What’s happening to generic drug prices? July 2019 NADAC Survey Update

It’s NADAC survey results week, which means it’s time for our next installment of “what happened to generic drug prices last month.” We saw a lot of price increases this past month, and an overall decrease in annualized spending, after a couple months of concerning trends. As always, the details matter, and we’re here to provide them for you. Check out our latest drug pricing report for a lot of important updates, plus an updated NADAC Packed Bubble Chart.

Ben LinkJuly 26, 2019NADAC, Medicaid, Generic, Concerta, Methylphenidate, Albenza, Daraprim, Albendazole, CorePharma, Impax, GlaxoSmithKline, Lineage, Gleevec, Imatinib, Xeloda, Capecitabine, Specialty